Benzothiazole compounds reduce blood glucose in diabetic rats
Benzothiazole-derived compounds are emerging as compelling preclinical candidates for diabetes management, demonstrating significant blood glucose reduction in rodent studies via enzyme modulation and AMPK pathway activation, according to mdpi.com reporting, ... Read More